A nationwide systematic survey of 97 organisations carried out by Swiss TPH shows that authorities, hospitals, institutions and organisations in Switzerland have long been committed to efforts against the flu.

On World Malaria Day 2019, Swiss organizations look back on a long history of successful public-private collaboration for new malaria medicines.

In Tanzania, two thirds of the population lacks basic health insurance. The Swiss Agency for Development and Cooperation (SDC) together with Swiss TPH and other partners now support the Tanzanian government in implementing a social health insurance scheme to address this gap.

Buruli ulcer is a neglected tropical disease (NTD) resulting in debilitating skin lesions, disabilities and stigmatisation.

Schistosomiasis is a parasitic worm infection affecting 250 million people globally. The current prevalence thresholds for preventive chemotherapy of intestinal schistosomiasis are based on the Kato-Katz method using stool samples.

A few days before his 90th birthday, Thierry Alfred Freyvogel-Jenny (4 May 1929 - 24 April 2019) passed away peacefully at home.

Fondation Botnar has awarded CHF 7 million to researchers from Lausanne for further deployment of electronic diagnostic and treatment tools based on algorithms, which will help clinicians to manage febrile children.

The debate on air quality standards for ambient air pollutants such as nitrogen oxide, particulate matter and ozone has revived in Germany last week.

Schistosomiasis is a parasitic worm infection affecting 250 million people globally. The current prevalence thresholds for preventive chemotherapy of intestinal schistosomiasis are based on the Kato-Katz method using stool samples.

The European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion of fexinidazole, the first all-oral treatment that has been shown to be efficacious for both stages of sleeping sickness.